Julie Freyberg
Family · Mankato, MNNPI 1407309578
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,200 of the $3,748 with a category attached, or 85.4%. Coloplast accounts for 85.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $2,687 and has fallen 64.8% since, to $944 in 2025. Among family clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 18 payments — averaging $208.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$3K
- Smith+Nephew$286
- Hydrofera LLC$107
- Takeda Pharmaceuticals U.S.A., Inc.$49
- Axonics, Inc.$47
- Medtronic$21
- plus $37 from 2 others
What the payments were for
- Consulting fees$3,20085%
- Food & beverage$54715%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 4 | $3,200 |
| Smith+Nephew | 4 | $286 |
| Hydrofera LLC | 1 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| Axonics, Inc. | 3 | $47 |
| Medtronic | 1 | $21 |
| Molnlycke Health Care US, LLC | 1 | $21 |
| Johnson & Johnson | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InterDry$2,368
- Biatain Ag Non-Adhesive$832
- GRAFIX PL$236
- STRAVIX PL$112
- Oasis$112
- CUTIMED SORBACT$107
How this compares
$3,748 in reported general payments places this provider in the 95th percentile of 1,121 family providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CholestyramineCholestyramine (With Sugar) | 18 | $1,982 |
| LoperamideLoperamide Hcl | 14 | $764 |
| Triamcinolone Acetonide | 59 | $552 |
| Doxycycline Monohydrate | 21 | $263 |
| Doxycycline Hyclate | 21 | $251 |
| Mupirocin | 16 | $175 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $170 |
| Ciprofloxacin Hcl | 12 | $48 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $45 |
| Tramadol Hcl | 12 | $18 |
Paid to pharmacies, not to this prescriber.
Other family in Mankato
- Shana PalmerMankato$17K
- Kelly LudvikMankato$2K
- Erin HewittMinnetonka$172K
- Julia GourdeMinneapolis$65K
- Robin DontaMinneapolis$60K
- Kristin WeberMinneapolis$35K
- Crista WenischBurnsville$30K
- Kathleen FredellMinneapolis$28K
- Christina RichardsonNorthfield$27K
- Diana CzelMinneapolis$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.